Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
A
Details...
Enter Symbol
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
Sector: Medical
Current Price :
$1.52
52 Week Low
$11.49
52 Week High
$26.92
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
20M
Market Cap:
$0.54B
Avg Volume:
104057
P/E Ratio:
673.000
PEG Ratio:
-0.010
Split:
On 11/19/2010 lgnd split by factor of 0.170
1m
3m
6m
1y
2y
Opinion and Analysis
Futures Gain After Claims Data; Amazon.Com (AMZN) Drops
Mar 14, 2013 08:56 AM |
AMZN
,
EBAY
,
ETFC
,
LGND
,
MW
,
SPPI
Spectrum Pharma (SPPI) Gains Development, Commercialization Rights To Melphalan
Mar 14, 2013 07:46 AM |
LGND
,
SPPI
Ligand Pharma (LGND) Receives Equity Milestone Payment From Retrophin
Jan 09, 2013 12:28 PM |
LGND
More Articles on LGND..
Press Releases
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated
May 17, 2013 12:52 PM |
LGND
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled(TM) Delafloxacin IV
May 14, 2013 08:30 AM |
LGND
Ligand Reports First Quarter Financial Results
May 08, 2013 04:00 PM |
LGND
More Press Releases on LGND..
SEC Filings
Form 4 LIGAND PHARMACEUTICALS For: Feb 15 Filed by: DeSilva Nishan M (10K)
Feb 19, 2013 03:59 PM
Form 4 LIGAND PHARMACEUTICALS For: Feb 15 Filed by: FOEHR MATTHEW W (10K)
Feb 19, 2013 03:59 PM
Form 4 LIGAND PHARMACEUTICALS For: Jan 23 Filed by: LAMPERT MARK N (10K)
Jan 25, 2013 05:34 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
LGND
Compare to S&P
YTD
29.80 %
19.03 %
4 Weeks
4.87 %
4.98 %
12 Weeks
35.62 %
31.06 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
2,800.00 %
EPS Growth in Last Year:
12.50 %
Sales Growth in Last Quarter:
113.88 %
Sales Growth in Last Quarter:
5.40 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##